BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18287845)

  • 1. Tc-99m pertechnetate/sestamibi subtraction scan in a case of parathyroid carcinoma.
    Singhal T; Jacobs M; Mantil JC
    Clin Nucl Med; 2008 Mar; 33(3):196-7. PubMed ID: 18287845
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
    Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
    J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.
    Leslie WD; Dupont JO; Bybel B; Riese KT
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1566-70. PubMed ID: 12458389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillary thyroid carcinoma associated with parathyroid adenoma detected by pertechnetate-MIBI subtraction scintigraphy.
    Rubello D; Toniato A; Pelizzo MR; Casara D
    Clin Nucl Med; 2000 Nov; 25(11):898-900. PubMed ID: 11079587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid adenomas without sestamibi retention.
    Leslie WD; Riese KT; Dupont JO; Peterdy AE
    Clin Nucl Med; 1995 Aug; 20(8):699-702. PubMed ID: 7586872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of Tc-99m sestamibi and Tc-99m tetrofosmin in a case of parathyroid adenoma.
    Mansi L; Rambaldi PF; Marino G; Pecori B; Del Vecchio E
    Clin Nucl Med; 1996 Sep; 21(9):700-3. PubMed ID: 8879870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of SPECT with (99m)Tc-Sestamibi in a patient affected by laryngeal carcinoma and parathyroid adenoma].
    Giordano A; Galli J; Corina L; Samanes Gajate AM; D'Andrea G; Almadori G
    Rev Esp Med Nucl; 2000 Jun; 19(3):211-4. PubMed ID: 11062085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tc-99m pertechnetate/sestamibi imaging in a case of recurrent parathyroid carcinoma with metabolic bone disorder.
    Meng Z; Tan J; Zhang M; Dong F; Jia Q; Zhang F
    Clin Nucl Med; 2009 Jul; 34(7):479-82. PubMed ID: 19542965
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed tc-99m sestamibi washout in graves' disease.
    Balan KK; Baltrop AH; Wishart GC
    Clin Nucl Med; 2003 Mar; 28(3):239-40. PubMed ID: 12592140
    [No Abstract]   [Full Text] [Related]  

  • 10. A retroesophageal parathyroid adenoma detected with Tc-99m sestamibi and MRI.
    Zentner J; Vogt H; Heidenreich P
    Clin Nucl Med; 1999 Dec; 24(12):998-9. PubMed ID: 10595493
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of artificial neural network algorithm to detection of parathyroid adenoma.
    Stefaniak B; Cholewiński W; Tarkowska A
    Nucl Med Rev Cent East Eur; 2003; 6(2):111-7. PubMed ID: 14737724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [99m Tc-sestamibi in the diagnosis of the location of hyperparathyroidism].
    Berná Roqueta L
    Rev Esp Med Nucl; 1998; 17(2):102-11. PubMed ID: 9611280
    [No Abstract]   [Full Text] [Related]  

  • 13. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
    Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
    J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic thyroid tissue on thallium/technetium parathyroid scan.
    Asp A; Hasbargen J; Blue P; Kidd GS
    Arch Intern Med; 1987 Mar; 147(3):595-6. PubMed ID: 3030213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brown tumor of the sternum: a potential source of false-positive Tl-201 and Tc-99m subtraction imaging in the mediastinum.
    Kumar R; Gupta R; Malhotra A
    Clin Nucl Med; 2000 Jan; 25(1):44-7. PubMed ID: 10634530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tc-99m sestamibi and I-123 detection of a parathyroid adenoma in the presence of a cold thyroid nodule.
    Jeanguillaume C; Hindie E; Meignan-Debray S; Melliere D; Galle P
    Clin Nucl Med; 1997 Apr; 22(4):258-60. PubMed ID: 9099488
    [No Abstract]   [Full Text] [Related]  

  • 17. Parathyroid adenomas evaluated by Tl-201/Tc-99m pertechnetate subtraction scintigraphy and high-resolution ultrasonography.
    Winzelberg GG; Hydovitz JD; O'Hara KR; Anderson KM; Turbiner E; Danowski TS; Lippe RD; Melada GA; Harrison AM
    Radiology; 1985 Apr; 155(1):231-5. PubMed ID: 2983373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of parathyroid carcinoma visualized on Tc-99m-sestamibi scintigraphy.
    Aigner RM; Fueger GF; Lax S
    Nuklearmedizin; 1997 Oct; 36(7):256-8. PubMed ID: 9394362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
    Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
    J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium Tc 99m sestamibi sensitivity in oxyphil cell-dominant parathyroid adenomas.
    Bleier BS; LiVolsi VA; Chalian AA; Gimotty PA; Botbyl JD; Weber RS
    Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):779-82. PubMed ID: 16847189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.